Alpha Teknova, Inc. (TKNO)
2.29
+0.03
(+1.33%)
USD |
NASDAQ |
Feb 26, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Alpha Teknova Research and Development Expense (Quarterly) : 0.542M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 15.91M |
| Nephros, Inc. | 0.338M |
| Spero Therapeutics, Inc. | 8.597M |
| Pyxis Oncology, Inc. | 17.35M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |